PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 6, 2010, Pages 1237-1242

  Shi, Wanliang ^a   Zhang, Ying ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antibiotics; Mutants; Mycobacterial persistence

Indexed keywords

BACTERIAL PROTEIN; PROTEIN PHOY1; PROTEIN PHOY2; PYRAZINAMIDE; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MUTANT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERSISTENT INFECTION; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI PROTEINS; FEMALE; GENE KNOCKOUT TECHNIQUES; LUNG; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; RIFAMPIN; SPLEEN; TRANSCRIPTION FACTORS; TUBERCULOSIS; VIRULENCE FACTORS;

EID: 77953522110     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq103     Document Type: Article

References (30)

1. WHO. World Health Organization Tuberculosis (TB). http://www.who.int/tb/en/(9 October 2009, date last accessed).
2. CDC. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55: 301-5.
3. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575-80.
4. WHO. XDR-TB, Extensively Drug-Resistant Tuberculosis. http://www.who. int/tb/challenges/xdr/en/index.html (21 September 2009, date last accessed).
5. McDermott W. Microbial persistence. Yale J Biol Med 1958; 30: 257-91.
6. Zhang Y. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 2005; 45: 529-64.
7. Mitchison D. The search for new sterilizing anti-tuberculosis drugs. Front Biosci 2004; 9: 1059-72.
8. Hobby GL, Meyer K, Chaffee E. Observations on the mechanism of action of penicillin. Proc Soc Exp Biol NY 1942; 50: 281-5.
9. Bigger JW. Treatment of staphylococcal infections with penicillin. Lancet 1944; 244: 497-500.
10. Balaban NQ, Merrin J, Chait R et al. Bacterial persistence as a phenotypic switch. Science 2004; 305: 1622-5.
11. Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5: 48-56.
12. Moyed HS, Bertrand KP. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 1983; 155: 768-75.
13. Pandey DP, Gerdes K. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res 2005; 33: 966-76.
14. Keren I, Shah D, Spoering A et al. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 2004; 186: 8172-80.
15. Korch SB, Henderson TA, Hill TM. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 2003; 50: 1199-213.
16. Li Y, Zhang Y. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother 2007; 51: 2092-9.
17. Vazquez-Laslop N, Lee H, Neyfakh AA. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol 2006; 188: 3494-7.
18. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000; 406: 735-8.
19. Dahl JL, Kraus CN, Boshoff HI et al. The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci USA 2003; 100: 10026-31.
20. Bardarov S, Kriakov J, Carriere C et al. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1997; 94: 10961-6.
21. Zhang Y, Garbe T, Young D. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol 1993; 8: 521-4.
22. Wade MM, Zhang Y. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro. J Antimicrob Chemother 2006; 58: 936-41.
23. Orme IM. A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis 1988; 137: 716-8.
24. Hansen S, Lewis K, Vulic M. The role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother 2008; 52: 2718-26.
25. Ma C, Sim S, Shi W et al. Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli. FEMS Microbiol Lett 2009; Nov 17 [Epub ahead of print].
26. Steed PM, Wanner BL. Use of the rep technique for allele replacement to construct mutants with deletions of the pstSCAB-phoU operon: evidence of a new role for the PhoU protein in the phosphate regulon. J Bacteriol 1993; 175: 6797-809.
27. Domka J, Lee J, Bansal T et al. Temporal gene-expression in Escherichia coli K-12 biofilms. Environ Microbiol 2007; 9: 332-46.
28. Glover WA, Yang Y, Zhang Y. Insights into the molecular basis of L-form formation and survival in Escherichia coli. PLoS One 2009; 4: e7316.
29. Lee K, Jung J, Kim K et al. Overexpression of outer membrane protein OprT and increase of membrane permeability in phoU mutant of toluene-tolerant bacterium Pseudomonas putida GM730. J Microbiol (Seoul, Korea) 2009; 47: 557-62.
30. Betts J, Lukey P, Robb L et al. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002; 43: 717-31.